On World Cancer Day, EASL warmly welcomes Europe’s Beating Cancer Plan
4 February 2021 The month of February brings together several key actions to tackle cancer globally, and EASL is focussing particularly on the global threat of liver cancer. EASL draws on all…
Liver community fights liver cancer with a robust action plan
Digital Liver Cancer Summit 2021: As the latest data suggests, liver cancer is now the third-most deadly cancer in the world, claiming nearly 1 million lives in 2020, the liver community takes…
A tribute to two driving forces in hepatology: Profs Gerok and Groszmann
In memoriam: Prof. Wolfgang Gerok (1926–2021) and Prof. Roberto Groszmann (1939–2021) 20 January 2021 EASL is greatly saddened to hear of the passing earlier this week of two giants of hepatology, Prof.…
Significant improvements in mechanistic biomarkers of how Dialive™ improves organ function
About EASL and the ALIVER Consortium The ALIVER Consortium of 11 institutions from seven European countries developed an innovative liver dialysis machine called Dialive™. This device helps the liver to regenerate naturally…
Looking towards bright horizons for 2021
This year has been unlike any other. COVID-19 brought unimaginable challenges to the medical community, placing you at the forefront of the pandemic. The year 2020 posed unique questions to those of…
Call for nominations for two new Scientific Committee members to join the EASL Governing Board
Are you deeply engaged in both hepatology and science and ready to get involved in EASL’s governance? EASL is now calling for nomination of two new Scientific Committee members to join the Governing Board. The term for these members is…
Study identifies causes precipitating the most serious stage of cirrhosis
Researchers from EF Clif identify the causes that precipitate the onset of the most serious stage of cirrhosis: the syndrome of Acute-On-Chronic Liver Failure (ACLF). Barcelona, December 9, 2020 – A new investigation…